Esperion Theraptc
(ESPR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 144,911 | 124,775 | 159,399 | 122,940 | 150,364 |
| Marketable Securities | 17,427 | 42,086 | 29,942 | 62,905 | 68,138 |
| Receivables | 36,415 | 33,729 | 31,489 | 27,844 | 25,116 |
| Inventories | 39,352 | 35,201 | 29,545 | 29,232 | 35,654 |
| Other current assets | 5,584 | 9,866 | 9,211 | 9,184 | 10,849 |
| TOTAL | $250,605 | $246,683 | $261,785 | $252,478 | $290,819 |
| Non-Current Assets | |||||
| PPE Net | 83 | 164 | 256 | 361 | 511 |
| Intangibles | 56 | 56 | 56 | 56 | 56 |
| Other Non-Current Assets | 1,075 | 1,036 | 50,730 | 51,085 | 51,467 |
| TOTAL | $1,214 | $1,256 | $51,042 | $51,502 | $52,034 |
| Total Assets | $251,819 | $247,939 | $312,827 | $303,980 | $342,853 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,065 | 23,040 | 18,580 | 12,832 | 26,829 |
| Accrued Expenses | 4,617 | 27,413 | 3,996 | 11,420 | 3,652 |
| Other current liabilities | 26,921 | 24,760 | 19,636 | 21,972 | 13,392 |
| TOTAL | $95,486 | $92,308 | $82,345 | $82,275 | $79,085 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 12,157 | 3,507 | 4,045 | 5,028 | 3,795 |
| Other Non-Current Liabilities | 485,996 | 479,409 | 524,582 | 513,192 | 512,386 |
| TOTAL | $485,996 | $479,409 | $524,582 | $513,403 | $512,808 |
| Total Liabilities | $581,482 | $571,717 | $606,927 | $595,678 | $591,893 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 94,713 | 76,573 | 73,684 | 66,552 | 63,007 |
| Common Shares | 87 | 75 | 72 | 65 | 61 |
| Retained earnings | -1,401,755 | -1,340,036 | -1,284,549 | -1,229,432 | -1,163,108 |
| Other shareholders' equity | 1 | 0 | -91 | -295 | -261 |
| TOTAL | $-329,663 | $-323,778 | $-294,100 | $-291,698 | $-249,040 |
| Total Liabilities And Equity | $251,819 | $247,939 | $312,827 | $303,980 | $342,853 |